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1. Introduction
1.1. Evidence of effects of omega-3 polyunsaturated fatty acids on depression and anxiety
disorder
Omega-3 polyunsaturated fatty acids (omega-3 PUFAs) such as eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA) are essential fatty acids that cannot be synthesized by
humans de novo and must therefore be obtained through the diet. Omega-3 PUFAs are
speculated to be beneficial against psychiatric disorders, especially depression, and an
increasing growing number of randomized controlled trials (RCTs) have been carried out to
verify their efficacy. In fact, a number of previous meta-analyses of RCTs support the positive
effects of omega-3 PUFAs supplementation in reducing depressive symptoms [1-7]. However,
a recent meta-analysis by Bloch and Hannestad in 2011 found that nearly all evidence of
omega-3 PUFAs benefit was removed after adjusting for publication bias [8]. Their meta-
analysis has subsequently been criticized by two papers published in quick succession [6, 7].
One of these papers, by Martins et al [6], pointed out methodological flaws with Bloch and
Hannestad's analysis. For example, Bloch and Hannestad’s analysis included the study
examining individuals without formal psychiatric diagnosis, and 2 other studies satisfying
their inclusion criteria were not included. Martins et al concluded that supplements containing
EPA ≥60% of total EPA + DHA were effective against depression, a finding in agreement with
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a meta-analysis by Sublette et al [5]. Taken together, then, the latest evidence does suggest the
efficacy of omega-3 PUFAs containing EPA ≥60% against depression.
Several biological mechanisms potentially explain the effect of omega-3 PUFAs in depression
and anxiety disorder [1]. To date, however, few RCTs have been carried out to investigate
whether omega-3 PUFAs are effective against anxiety disorders. While one such study
suggested that omega-3 PUFAs might not be effective for patients suffering from depression
with comorbid anxiety disorder [9], some RCTs found that omega-3 PUFAs decreased hostility
and aggression among patients with borderline personality disorder [10].
1.2. Omega-3 polyundasurated fatty acids and inflammation
A competitive interaction exists between omega-6 polyunsaturated fatty acids (omega-6
PUFAs) such as arachidonic acid (AA) and omega-3 PUFAs in regard to their shared enzymatic
pathways. Compared with the eicosanoids produced from AA, such as prostaglandin E2
(PGE2), those produced from omega-3 PUFAs, such as prostaglandin E3 (PGE3), have little
pro-inflammatory activity [11]. Therefore, it is speculated that the amounts of omega-6
eicosanoids released in response to depression-associated inflammation and cell apoptosis,
are determined by the fatty acid composition of the cell membrane phospholipids [12]. On this
basis, it is thought that increased levels of omega-3 PUFAs in the cell membranes reduces the
release of AA-derived prostaglandins, thereby reducing inflammatory activity [13].
Naturally occurring depression-related cell apoptosis may be mediated by free radicals that
appear in the brain during the process of inflammatory or ischemic damage. Inflammation and
ischemia are known to increase the risk for clinically defined depression [14]. Taken into
account that cytokines stimulate the intrinsic pathway of apoptosis and induce depression [15,
16], it is not altogether surprising to find frequent comorbidity of inflammation and depression.
The interaction between omega-6 and omega-3 PUFAs eicosanoids, therefore, partly control
inflammation, apoptosis and depression as a result [14].
1.3. Omega-3 polyunsaturated fatty acids and neurogenesis
The severity of depression is known to be associated with serum brain-derived neurotrophic
factor (BDNF) [17], which exerts various effects on the nervous system, including neuronal
outgrowth, differentiation, synaptic connectivity, and neuronal repair and survival [18-20]. Its
severity is also associated with low levels of erythrocyte omega–3 PUFAs [21]. Short-term
dietary supplementation with omega-3 PUFAs has been shown to up-regulate adult neuro‐
genesis in lobsters [22]. In rats, dietary omega-3 PUFAs increased levels of BDNF, which
promotes neuronal survival and growth [23].DHA extended neurites and branches of rat
hippocampal neurons in vitro [24]. DHA supplementation to rats also promoted the matura‐
tion of neurons and hippocampal neurogenesis in vivo [25].. On the basis of these findings,
omega-3 PUFAs supplementation can enhance the effect of BDNF-related synaptic plasticity
and neurogenesis.
Additionally, in PTSD, the pathogenesis of which is characterized by excess consolidation of
fear memory and failure of extinction learning [26], it might be possible to control fear memory
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by regulating hippocampal neurogenesis [27]. Indeed, in mice with active hippocampal
neurogenesis, the period of hippocampus-dependent fear memory was found to be shorter
[28]. Given the findings of animal research conducted to date, omega-3 PUFAs seem to be the
most promising candidate for dietary intervention to facilitate adult hippocampal neurogen‐
esis following a traumatic event [25, 29]. In fact, in an open label trial in patients with physically
injury, we previously found that PTSD symptoms were significantly alleviated by taking
DHA-rich fish oil [30].
1.4. Background of the study
On March 11, 2011, The Great East Japan Earthquake and tsunami devastated the northeastern
coast of Japan. As of July 18th, 2012, 15,867 died and 2,906 were missing arrocding to the
National Police Agency. Many rescue workers, as well as survivors, were exposed to traumatic
experiences. A number of studies have reported adverse psychological outcomes among
rescue workers. In a study of medical care personnel sent to aid trauma victims of an airline
crash, 13.5% developed PTSD within 18 months of the crash [31]. Similarly, in a study of rescue
workers deployed to the site of the September 11 terrorist attack in New York in 2001, 16.7%
developed PTSD and 21.7% developed depression at 13 months after the attack [32]. Moreover,
peritraumatic distress (distress during and right after a traumatic experience) and TV viewing
for extended periods were shown to predict PTSD symptoms in rescue workers [33, 34]. PTSD
is associated with higher psychiatric comorbidity, attempted suicide, and physical illnesses
[35], as well as with high medical expenses [36]. An appropriate strategy for the prevention of
PTSD in rescue workers is therefore clearly required, but as yet adequate measures have not
been developed.
Against this background, we carried out a study to determine whether fish oil supplementation
can attenuate PTSD symptoms among rescue workers after the Great East Japan Earthquake.
The main findings have been breifly reported elsewhere [37] and here we present the overall
findings of the study.
2. Methods
2.1. Participants
This trial named “Attenuating posttraumatic distress with omega-3 polyunsaturated fatty
acids among disaster medical assistance team members after the Great East Japan Earthquake
(APOP)” was a single-blind, randomized, parallel-group field trial administered by the
National Disaster Medical Center (NDMC), Tokyo, Japan. The head office of the Disaster
Medical Assistance Team (DMAT) is located at NDMC. DMAT members are doctors, nurses,
and operational coordination staff (medical or clerical staff who are neither doctors nor nurses)
who are dispatched as a mobile medical team with specialized training that is capable of acting
during the acute phase of a large-scale disaster. DMAT activities commenced on the day of the
Great East Japan Earthquake, March 11, and concluded on March 22.
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The DMAT members recruited to the present trial met the following inclusion criteria: 1) aged
18 years or older; 2) a native Japanese speaker or non-native speaker with Japanese conversa‐
tional abilities; and 3) physically and psychologically capable of understanding and providing
consent for study participation. The exclusion criterion was regular intake of warfarin for at
least 3 months before deployment, because Fish oil supplementation could have provided
additional anticoagulation with warfarin.
2.2. Procedures
The detailed trial procedures have been reported elsewhere [38], but briefly a written guide to
the study, including an explanation of the study and informed consent, was posted to the
Emergency Medical Information System by DMAT head office and a mass email was sent to
all DMAT members asking for their participation. The Peritraumatic Distress Inventory (PDI)
[39, 40] was used to quantify peritraumatic distress. Other detailed baseline assessment has
been reported elsewhere [38].
2.3. Ethics
The study protects the rights and welfare of participants in the spirit of ethical guidelines
outlined under the Declaration of Helsinki, and further respects the ethical principles of the
Ministry of Health, Labour, and Welfare of Japan. The study was approved by the Ethics
Committee of the NDMC on April 1, 2011. Individual participants in this study gave written
informed consent.
2.4. Interventions
For participants allocated to the fish oil plus psychoeducation group, seven capsules per day,
each containing 320 mg of fish oil, were provided in line with previous research [41]. The fish
oil composition of each capsule was 70% DHA and 7% eicosapentaenoic acid (EPA). Each
capsule was placed in a brown 500-ml polyethylene container with a wide opening. Partici‐
pants were instructed to take the capsules after eating and additionally told that they might
take a full day’s dosage at one time. For participants of both groups, a leaflet on psychoedu‐
cation about posttraumatic distress focusing on critical incident stress was provided.
2.5. Objectives
This study aimed to determine whether fish oil supplementation can attenuate the symptoms
of PTSD and other posttraumatic distress such as depression among DMAT workers who were
deployed during the acute disaster phase of the Great East Japan Earthquake.
2.6. Outcomes
The primary outcome was total score on the Impact of Event Scale-Revised (IES-R) at 12 weeks
after shipment of the supplements on April 19, 2011. The IES-R, developed by Weiss, is a self-
reporting questionnaire about PTSD symptoms and is the most widely used measure inter‐
nationally in all forms of disaster-area research [42]. The IES-R is composed of 22 items on the
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three largest symptoms in the diagnostic criteria of PTSD, namely re-experiencing, avoidance,
and hyperarousal. Respondents rate symptoms experienced in the previous week. The validity
and reliability of the Japanese version of the IES-R has been confirmed [43].
Secondary outcomes were the total scores on each of the Kessler 6 Scale, the Center for
Epidemiologic Studies Depression Scale (CES-D), and the shortened 14-item version of the
Resilience Scale at 12 weeks after shipment of the supplements. the Kessler 6 Scale, developed
by Kessler et al. [44], is a self-reporting questionnaire designed to screen for psychiatric
disorders and mood and anxiety disorders; the CES-D, developed by Radloff [45], is a self-
reporting questionnaire on depression; and the shortened 14-item version of the Resilience
Scale, developed by Wagnild and Young [46], is a self-reporting questionnaire for quantitative
evaluation of resilience. The Japanese version of each of these three scales has been validated
[47-49].
Safety of the intervention was evaluated by the presence of adverse events during the obser‐
vation period, by asking the participants about the presence of such events at 2, 4, 8, and 12
weeks after the start of fish oil supplementation. Whenever inquiries were received from
participants, necessary information was provided to them.
2.7. Sample size
We estimated that the mean improvement in IES-R score as the primary outcome measure
would be 10 (SD 15) for the fish oil plus psychoeducation group and 0 (SD 15) for the psycho‐
education alone group [30]. We set α level at.05 and β at.10. This brought us to our required
sample size estimation of 48 cases per group. Because the control group in this study received
psychoeducation, we allowed up to 150 cases for the intervention group and 300 cases for the
control group.
2.8. Randomization
Participants were randomly assigned to either the fish oil supplementation plus psychoedu‐
cation group or psychoeducation alone group. The trial statisticians (NN and TS) independ‐
ently conducted randomization by the permuted block method using a four-person block, and
concealed allocation mechanism until the study was finished. The participants were stratified
by sex because previous studies showed that the prevalence of PTSD and of major depressive
disorder was higher in women than in men [50].
2.9. Blinding
Because placebo capsules were not provided to psychoeducation alone group, participants
could not be masked. Also, the researcher who provided necessary information regarding
safety management to the participants (DN) could not be masked in just a few cases when
participants inadvertently stated that they took the fish oils capsules. Other researchers were
masked to allocation.
PTSD and the Attenuating Effects of Fish Oils: Results of Supplementation After the 2011 Great East Japan Earthquake
http://dx.doi.org/10.5772/52134
411
2.10. Statistical methods
All analyses were conducted according to the intention-to-treat principle. A sensitivity analysis
was performed using a multiple imputation procedure with SAS version 9.1 (SAS Institute Inc,
Cary, North Carolina) to impute each psychological variable end point for participants who
did not have a follow-up psychological variable assessed.
Analysis of covariance (ANCOVA) was used to investigate the significance of the differences
in the initial values as well as those of the net changes after the intervention among the 2 groups,
95% confidence interval values, and P values. Covariates for ANCOVA were sex, age, and each
psychological variable score at baseline. In addition, we examined the impact of sex difference
for fish oil supplementation on posttraumatic distress. A two-tailed test was used, with the
α level set at 0.05.
3. Results
3.1. Participants flow and recruitment
Figure 1 shows the trial profile. Of the 1,816 DMAT workers deployed to the disaster areas,
172 were enrolled and randomly allocated to the fish oil plus psychoeducation group or
psychoeducation alone group between April 2 and 12, 2011 (Figure 1). The mean duration from
baseline assessment to follow-up assessment was 14.2 weeks (SD 0.9), and from shipment of
the supplements to follow-up assessment was 12.6 weeks (SD 0.8). Only 1 participant in the
psychoeducation alone group was lost to follow-up.
3.2. Baseline data
The two groups were well balanced with respect to baseline characteristics, except that the
IES-R total and intrusion subscale scores were relatively high in the intervention group (Table
1). The mean term of the deployment was 4.1 days (SD 2.0). Two participants (1%) were injured
during deployment, 11 (6%) saved children, 24 (14%) had contact with corpses, and the median
of the PDI was 12.5 (range 0-42). These variables, identified as risk factors for PTSD in previous
research [31, 51], did not differ significantly between the two groups. The PDI scores were
comparable to those in accident survivors (Median 15.0, range 0-40] [52, 53].
3.3. Numbers analyzed
Eighty-six participants were assigned to each group. Primary outcome data were available for
all participants, except one. All participants constituted the intention-to-treat population. The
imputation technique assigned changes in the effectiveness end point for the noncompleter
based on the participant’s baseline characteristics and baseline psychological variables.
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1,816 rescue workers invited to participate 
Excluded (n= 1,644) 
  1390 did not respond 
  254 did not participate in the trial 
86 included in analysis 
86 completed 12-weeks 
follow-up 
86 allocated to fish oils plus 
psychoeducation 
86 received fish oils plus 
psychoeducation 
85 completed 12-weeks 
follow-up 
1 lost to follow-up 
86 allocated to 
psychoeducation alone 
86 received psychoeducation 
86 included in analysis 
172 randomized 
Figure 1. Flow diagram of the study
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Fish oil plus
psychoeducation
group (n=86)
Psychoeducation
alone group (n=86)
P value*1
Demographic data
Age in years (mean±S.D.) 37.9 ± 7.4 37.4 ± 7.4 0.62
Women (%) 27.9 26.7 0.86
BMI (mean±S.D.) 22.7 ± 2.8 23.0 ± 3.0 0.50
Occupation (%) 0.87
Medical Doctor 26.7 24.4
Nurse 46.5 45.4
Other 26.7 30.2
Years of occupational experience (mean±S.D.) 14.5 ± 7.2 13.2 ± 7.3 0.24
Previous disaster operation experience (%) 27.9 26.7 0.86
Married (%) 67.4 72.1 0.51
Has a child (or children) (%) 57.0 61.6 0.53
Education (%)
University or higher 47.7 53.5 0.45
Current smoker (%) 29.1 23.3 0.39
Current drinker (%) 80.2 83.7 0.55
Has past history of any physical disaeses*2 (%) 0.0 0.0 -
Has past history of depression (%) 0.0 4.7 -
Psychological data
IES-R (mean±S.D.)
IES-R-Total 14.5 ± 15.1 10.7 ± 11.5 0.07
IES-R-Intrusion 6.5 ± 6.6 4.7 ± 5.1 0.05
IES-R-Avoidance 4.0 ±5.2 3.0 ± 4.2 0.16
IES-R-Hyperarousal 3.9 ± 4.6 2.9 ± 3.6 0.12
K6 (mean±S.D.) 4.5 ± 5.0 3.4 ± 4.2 0.13
CES-D (mean±S.D.) 13.6 ± 9.1 11.6 ± 8.1 0.13
RS-14 (mean±S.D.) 65.5 ± 10.3 67.1 ± 9.9 0.31
Abbreviations: IES-R, Impact of Event Scale-Revised; K6, Kessler 6 Scale; CES-D, Center for Epidemiologic Studies
Depression Scale; RS-14, Resilience Scale 14-item version
*1) Student's t test or Chi-square test
*2) Physical disease defined as cancer, cardiovascular disease, stroke, chronic renal disease, chronic liver disease, and
accidental injury.
Table 1. Characteristics of the study population at randomization
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3.4. Outcomes and estimation
ANCOVA adjusted for sex and age showed a significant reduction in IES-R intrusion and
hyperarousal subscale scores in the fish oil plus psychoeducation group. When adjusted for
the scores at baseline, however, no significant difference in primary outcome was seen between
the two groups when adjusted for the scores at baseline (-0.9, 95% CI, -3.0 to 1.2; P = 0.39) and
no significant differences were seen in any of secondary outcomes (Table 2).
Variables Baseline
(mean±S.D.)
After 12
weeks
(mean±S.D.)
Net
change 1
(95% CI)
P value Net change 2
(95% CI)
P value
IES-R-Total
Fish oils group 14.5 ± 15.1 9.0 ± 9.5 -2.7
(-5.5, 0.1)
0.06 -0.9
(-3.0, 1.2)
0.39
Control group 10.7 ± 11.5 7.9 ± 10.0
IES-R-Intrusion
Fish oils group 6.5 ± 6.6 3.3 ± 3.4 -1.5
(-2.8, -0.2)
0.03 -0.5
(-1.3, 0.4)
0.28
Control group 4.7 ± 5.1 3.1 ± 3.7
IES-R-Avoidance
Fish oils group 4.0 ± 5.2 3.3 ± 4.4 -0.04
(-1.0, 0.9)
0.94 0.3
(-0.5, 1.1)
0.44
Control group 3.0 ± 4.2 2.4 ± 3.7
IES-R-Hyperarousal
Fish oils group 3.9 ± 4.6 2.3 ± 2.7 -1.1
(-2.1, -0.1)
0.03 -0.6
(-1.4, 0.1)
0.11
Control group 2.9 ± 3.6 2.5 ± 3.5
K6
Fish oils group 4.5 ± 5.0 2.9 ± 3.4 -0.4
(-1.5, 0.8)
0.52 0.2
(-0.6, 1.1)
0.62
Control group 3.4 ± 4.2 2.2 ± 3.7
CES-D
Fish oils group 13.6 ± 9.1 10.8 ± 6.3 -1.5
(-3.9, 0.8)
0.20 -0.3
(-2.1, 1.5)
0.73
Control group 11.6 ± 8.1 10.3 ± 7.2
RS-14
Fish oils group 65.5 ± 10.3 67.2 ± 11.3 2.7
(-0.4, 5.8)
0.09 2.2
(-0.8, 5.2)
0.15
Control group 67.1 ± 9.9 66.1 ± 13.3
Abbreviations: IES-R, Impact of Event Scale-Revised; K6, Kessler 6 Scale; CES-D, Center for Epidemiologic Studies
Depression Scale; RS-14, Resilience Scale 14-item version; CI, confidence interval
Net change 1: Analysis of covariance (ANCOVA) adjusted for sex and age
Net change 2: Analysis of covariance (ANCOVA) adjusted for sex, age and each psychological variable score at baseline
Table 2. Change in IES-R, K6, CES-D and RS-14 scores of participants in the fish oils and control groups
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Because previous studies showed that the prevalence of PTSD and of major depressive
disorder was higher in women than in men [50], subgroup analysis by sex was pre-specified.
In women, the IES-R total mean score was reduced from 15.7 (SD 14.9) at baseline to 9.3 (SD
8.8) at follow-up in the fish oil plus psychoeducation group, compared to that from 11.2 (SD
13.0) to 10.4 (SD 12.3) in the psychoeducation alone group. In men, the IES-R total score was
reduced in both groups, from 14.0 (SD 15.3) to 8.9 (SD 9.9) in the fish oil plus psychoeducation
group and from 10.5 (SD 11.1) to 6.9 (SD 9.0) in the psychoeducation alone group. Remarkably,
even when adjusted for age and IES-R scores at baseline, change in the IES-R score of women
in the two groups from baseline to 12weeks was -3.9 (95% CI, -7.5 to -0.3; P = 0.04) (Table 3).
Regarding adherence, 7 out of 86 participants (8%; 6 male, 1 female) in the fish oil plus
psychoeducation group took fish oil supplements 2 days or less per a week.
3.5. Adverse events
The occurrence rate of adverse events was not significantly different between the two groups,
with 32 participants (37%) in the fish oil plus psychoeducation group reporting at least one
adverse event versus 22 (26%) of the psychoeducation alone group doing so. Of these events,
none were regarded as serious or led to withdrawal. The main adverse events included loose
bowel (21 (24%) in the fish oil plus psychoeducation group versus 15 (17%) in the psychoedu‐
cation alone group) and belching (12 (14%) in the fish oil plus psychoeducation group versus
7 (8%) in the psychoeducation alone group).
4. Discussion
4.1. Interpretation
This trial regretfully did not show the superiority of fish oil supplementation plus psycho‐
education over psychoeducation alone for the prevention of PTSD and depressive symptoms
among rescue workers. Even though a relatively good improvement was seen in IES-R score
in the fish oil plus psychoeducation group, the improvement did not reach statistical signifi‐
cance. Furthermore, we recorded no significant differences between the two groups for the 3
secondary outcomes.
One of the possible reasons for not detecting the effectiveness of fish oil supplementation was
that posttraumatic distress was reduced in both groups. A previous study of disaster workers
at the September 11 terrorist attack sites showed that depressive symptoms were increased
from 7 months after the disaster to 13 months after, while PTSD symptoms were reduced from
1 week to 13 months afterward [32]. In the present study, all psychological variables were
reduced to some extent in both groups. Participants in both groups were contacted at 2, 4, 8,
and 12 weeks for safety management and necessary information was provided to them upon
request for ethical reasons: such contact might have been supportive for both groups of
participants. Psychoeducation provided before the baseline assessment also might affect the
results.
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Variables Net change (95% CI) P value
IES-R-Total
Women -3.9 (-7.5, -0.3) 0.04
Men 0.2 (-2.2, 2.7) 0.86
IES-R-Intrusion
Women -1.3 (-2.9, 0.4) 0.12
Men -0.1 (-1.1, 0.8) 0.78
IES-R-Avoidance
Women -0.4 (-1.9, 1.1) 0.58
Men 0.6 (-0.4, 1.6) 0.23
IES-R-Hyperaruosal
Women -1.9 (-3.4, -0.5) 0.009
Men -0.1 (-1.0, 0.8) 0.77
K6
Women 0.1 (-1.9, 2.1) 0.90
Men 0.2 (-0.7, 1.2) 0.61
CES-D
Women -2.8 (-6.4, 0.8) 0.13
Men 0.5 (-1.5, 2.6) 0.60
RS-14
Women 3.7 (-1.5, 9.0) 0.16
Men 1.7 (-2.0, 5.4) 0.36
Abbreviations: IES-R, Impact of Event Scale-Revised; K6, Kessler 6 Scale; CES-D, Center for Epidemiologic Studies
Depression Scale; RS-14, Resilience Scale 14-item version; CI, confidence interval
Net change: Analysis of covariance (ANCOVA) adjusted for age and each psychological variable score at baseline
Table 3. Change in IES-R, K6, CES-D and RS-14 scores of participants in the fish oils and control groups stratified by sex
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The fish oil capsules used in this study contained 1,568 mg DHA and 157 mg EPA per day.
Based on previous studies [25, 29], DHA rather than EPA appeared to facilitate adult hippo‐
campal neurogenesis. However, there is evidence to support the effectiveness of EPA mono‐
therapy or a combination of EPA and DHA for depressive disorders [1]. A recent review
showed that a 2:1 EPA:DHA ratio might be optimal for the treatment of depressive disorders
[54]. In fact, our open label trial in physically injured patients failed to alleviate depressive
symptoms, while alleviating PTSD symptoms [30]. To our knowledge, no previous studies
have examined the effectiveness of fish oils to prevent PTSD. The appropriate composition of
fish oil capsules to prevent PTSD warrants attention.
Remarkably, fish oil supplementation plus psychoeducation significantly lowered the IES-R
total and hyperarousal subscale scores in women, despite the small sample size of women. To
our knowledge, this is the first randomized controlled trial to show that fish oil reduced PTSD
symptoms in women. While this outcome could be caused by chance because this was a
secondary analysis, our finding coincides with that of previous longitudinal studies in Finland,
Spain, and the United States [55-57] showing dietary intake of fish decreased the risk of
developing depression in women, but not in men. Moreover, in Japan, a very low intake of fish
was found to be associated with increased risk of suicidal death in women [58]. Although the
difference in depressive symptoms assessed by the CES-D did not reach statistical signifi‐
cance among women in the present study, further studies with a large sample size may prove
the effectiveness of fish oil supplementation for attenuating depressive symptoms in women.
Also, our finding that women who took the fish oil supplements had a significant reduced score
on the hyperarousal subscale is also partly consistent with a previous study showing that DHA
intake prevented aggression from increasing at times of mental stress [41]. It is unclear why fish
oils play an important role for regulating psychological well-being only in women, but it could
be explained by the fact that estrogens cause higher DHA concentrations in women than in men
[59]. Future studies should determine the effect of the sex difference in the effectiveness of fish
oil supplementation for PTSD and posttraumatic depressive symptoms.
In addition to the possibility that fish oils do attenuate PTSD symptoms in women, it is well
known that fish oils are effective for the secondary prevention of cardiovascular disease. An
ecological study revealed that the availability of omega 3 PUFAs was inversely related with
disease rates in 12 risk models, such as mortality from stroke and cardiovascular disease, as
well as depression [60]. Given these positive effects on physical health and low rates of severe
adverse events, fish oil supplementation could be a safe and novel strategy for the prevention
of PTSD in women.
4.2. Generalizability
As shown in the figure 1, 1,390 out of 1,816 rescue workers invited to participate did not
respond, which could limit the external validity of the findings. This might be because many
rescue workers committed themselves to important roles at their own hospitals immediately
after their deployment and could hardly afford to participate in this study.
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4.3. Limitations
This study has some strengths. The participants are representative of all DMAT workers in that
they are based across Japan. Baseline assessments were conducted within 1 month after the
earthquake, which would minimize recall bias, and the attrition rate (<1%) was extremely low.
However, the study also has some limitations. First, this study was not a placebo controlled,
double-blind trial. Because this study was implemented at a time of crisis, we could not prepare
placebo capsules. It might be possible that we found a placebo effect acted more strongly in
women who took the fish oil supplements. We are currently implementing a double-blind,
placebo control trial of fish oils for the prevention of PTSD in physically injured patients
(ClinicalTrials.gov Identifier: NCT00671099]. Second, this study relied on self-reports of
adherence to the protocol, rather than biomarkers. We are currently measuring fatty acid
composition of red blood cell membranes in a double-blind controlled trial mentioned above.
Third, the finding of efficacy for women is driven by the significant reduction in hyperarousal
cluster symptoms. Hyperarousal cluster symptoms are not PTSD-specific and are similar to
the symptoms of other anxiety and mood disorders. Because assessment of PTSD is a self-
report screening instrument rather than a structural interview, this study could not rule out
an alternative explanation of the positive finding for women that attributes that difference to
changes that are not related to PTSD.
5. Conclusion
This trial did not show the effectiveness of fish oil supplementation for the prevention of PTSD
and depressive symptoms in rescue workers. However, the supplements did reduce PTSD
symptoms significantly in women. Due to limitations mentioned above, the result of this study
is a preliminary and should be accepted cautiously, but at the same time it is an encouraging
finding. Not only rescue workers but large numbers of people were traumatized by natural
disasters such as the Great East Japan Earthquake, and psychiatric resources to support them
have been limited. Against this background, daily life-based intervention for the prevention
of PTSD is preferable. Fish oil supplementation may offer a safe strategy for preventing PTSD
in women, and thus is an important topic that should be further explored in disaster mental
health care.
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